24-羟基化在维生素D代谢稳态调节中的关键作用。

Zhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, May E Montasser, Amber L Beitelshees, Simeon I Taylor
{"title":"24-羟基化在维生素D代谢稳态调节中的关键作用。","authors":"Zhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, May E Montasser, Amber L Beitelshees, Simeon I Taylor","doi":"10.1101/2023.06.27.23291942","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The body has evolved homeostatic mechanisms to maintain free levels of Ca<sup>+2</sup> and 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D] within narrow physiological ranges. Clinical guidelines emphasize important contributions of PTH in maintaining this homeostasis.</p><p><strong>Objective: </strong>To investigate mechanisms of homeostatic regulation of vitamin D (VitD) metabolism and to apply mechanistic insights to improve clinical assessment of VitD status.</p><p><strong>Design: </strong>Crossover clinical trial studying participants before and after VitD3-supplementation.</p><p><strong>Setting: </strong>Community.</p><p><strong>Participants: </strong>11 otherwise healthy individuals with VitD-deficiency (25-hydroxyvitamin D [25(OH)D] ≤20 ng/mL).</p><p><strong>Interventions: </strong>VitD3-supplements (50,000 IU once or twice a week depending on BMI, for 4-6 weeks) were administered to achieve 25(OH)D≥30 ng/mL.</p><p><strong>Results: </strong>VitD3-supplementation significantly increased mean 25(OH)D by 2.7-fold and 24,25-dihydroxyvitamin D [24,25(OH)<sub>2</sub>D] by 4.3-fold. In contrast, mean levels of PTH, FGF23, and 1,25(OH)<sub>2</sub>D did not change. Mathematical modeling suggested that 24-hydroxylase activity was maximal for 25(OH)D≥50 ng/mL and achieved a minimum (~90% suppression) with 25(OH)D<10-20 ng/mL. The 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio better predicted modeled 24-hydroxylase activity (<i>h</i>) (ρ=-0.85; p=0.001) compared to total plasma 25(OH)D (ρ=0.51; p=0.01) and the 24,25(OH)<sub>2</sub>D/25(OH)D ratio (ρ=0.37; p=0.3).</p><p><strong>Conclusions: </strong>Suppression of 24-hydroxylase provides a first line of defense against symptomatic VitD-deficiency by decreasing metabolic clearance of 1,25(OH)<sub>2</sub>D. The 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio provides a useful index of VitD status since it incorporates 24,25(OH)<sub>2</sub>D levels and therefore, provides insight into 24-hydroxylase activity. When VitD availability is limited, this suppresses 24-hydroxylase activity - thereby decreasing the level of 24,25(OH)<sub>2</sub>D and increasing the 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio. Thus, an increased 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio signifies triggering of homeostatic regulation, which occurs at early stages of VitD-deficiency.</p>","PeriodicalId":18659,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/c6/nihpp-2023.06.27.23291942v1.PMC10327282.pdf","citationCount":"0","resultStr":"{\"title\":\"Critical Role for 24-Hydroxylation in Homeostatic Regulation of Vitamin D Metabolism.\",\"authors\":\"Zhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, May E Montasser, Amber L Beitelshees, Simeon I Taylor\",\"doi\":\"10.1101/2023.06.27.23291942\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>The body has evolved homeostatic mechanisms to maintain free levels of Ca<sup>+2</sup> and 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D] within narrow physiological ranges. Clinical guidelines emphasize important contributions of PTH in maintaining this homeostasis.</p><p><strong>Objective: </strong>To investigate mechanisms of homeostatic regulation of vitamin D (VitD) metabolism and to apply mechanistic insights to improve clinical assessment of VitD status.</p><p><strong>Design: </strong>Crossover clinical trial studying participants before and after VitD3-supplementation.</p><p><strong>Setting: </strong>Community.</p><p><strong>Participants: </strong>11 otherwise healthy individuals with VitD-deficiency (25-hydroxyvitamin D [25(OH)D] ≤20 ng/mL).</p><p><strong>Interventions: </strong>VitD3-supplements (50,000 IU once or twice a week depending on BMI, for 4-6 weeks) were administered to achieve 25(OH)D≥30 ng/mL.</p><p><strong>Results: </strong>VitD3-supplementation significantly increased mean 25(OH)D by 2.7-fold and 24,25-dihydroxyvitamin D [24,25(OH)<sub>2</sub>D] by 4.3-fold. In contrast, mean levels of PTH, FGF23, and 1,25(OH)<sub>2</sub>D did not change. Mathematical modeling suggested that 24-hydroxylase activity was maximal for 25(OH)D≥50 ng/mL and achieved a minimum (~90% suppression) with 25(OH)D<10-20 ng/mL. The 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio better predicted modeled 24-hydroxylase activity (<i>h</i>) (ρ=-0.85; p=0.001) compared to total plasma 25(OH)D (ρ=0.51; p=0.01) and the 24,25(OH)<sub>2</sub>D/25(OH)D ratio (ρ=0.37; p=0.3).</p><p><strong>Conclusions: </strong>Suppression of 24-hydroxylase provides a first line of defense against symptomatic VitD-deficiency by decreasing metabolic clearance of 1,25(OH)<sub>2</sub>D. The 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio provides a useful index of VitD status since it incorporates 24,25(OH)<sub>2</sub>D levels and therefore, provides insight into 24-hydroxylase activity. When VitD availability is limited, this suppresses 24-hydroxylase activity - thereby decreasing the level of 24,25(OH)<sub>2</sub>D and increasing the 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio. Thus, an increased 1,25(OH)<sub>2</sub>D/24,25(OH)<sub>2</sub>D ratio signifies triggering of homeostatic regulation, which occurs at early stages of VitD-deficiency.</p>\",\"PeriodicalId\":18659,\"journal\":{\"name\":\"medRxiv : the preprint server for health sciences\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/c6/nihpp-2023.06.27.23291942v1.PMC10327282.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv : the preprint server for health sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2023.06.27.23291942\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv : the preprint server for health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2023.06.27.23291942","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

身体已经进化出有效的稳态机制,将Ca+2和1,25-二羟基维生素D[1,25(OH)2D]的游离水平维持在狭窄的生理范围内。文献记录了PTH对这种稳态调节的重要贡献。我们开发了一个机制数学模型,记录了24-羟化酶活性的稳态调节的重要贡献。维生素D(VitD)代谢产物水平的数据来自一项在健康参与者中进行的临床试验,基线总25-羟基维生素D[25(OH)D]水平≤20 ng/mL。该试验被设计为一项交叉试验,在该试验中,参与者在接受维生素D3补充之前和之后(≥4-6周)进行研究,以实现总25(OH)D水平>30 ng/mL。补充维生素D3使25(OH)D的平均水平显著增加2.7倍,使24,25-二羟基维生素D[24,25(OH,2D]的平均水平增加4.3倍。相反,PTH、FGF23和1,25(OH)2D的平均水平在补充维生素D3后没有变化。数学模型表明,当25(OH)D水平≥50 ng/mL时,24-羟化酶活性最大,而当25(OHD)水平为2D时,通过抑制1,25(OH)2D的代谢清除,24-羟基酶活性达到最小(约90%的抑制)。维生素D代谢产物比率[例如,1,25(OH)2D/24,25(OH-2D]提供了有用的指标,证明身体已经触发稳态调节来补偿维生素D的有限可用性。因此,24-羟化酶活性的抑制提供了防止维生素D缺乏症的第一道防线。在严重的维生素D缺乏症中,当第一道防线被最大限度地部署时,身体会触发继发性甲状旁腺功能亢进,从而提供第二道防线。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Critical Role for 24-Hydroxylation in Homeostatic Regulation of Vitamin D Metabolism.

Context: The body has evolved homeostatic mechanisms to maintain free levels of Ca+2 and 1,25-dihydroxyvitamin D [1,25(OH)2D] within narrow physiological ranges. Clinical guidelines emphasize important contributions of PTH in maintaining this homeostasis.

Objective: To investigate mechanisms of homeostatic regulation of vitamin D (VitD) metabolism and to apply mechanistic insights to improve clinical assessment of VitD status.

Design: Crossover clinical trial studying participants before and after VitD3-supplementation.

Setting: Community.

Participants: 11 otherwise healthy individuals with VitD-deficiency (25-hydroxyvitamin D [25(OH)D] ≤20 ng/mL).

Interventions: VitD3-supplements (50,000 IU once or twice a week depending on BMI, for 4-6 weeks) were administered to achieve 25(OH)D≥30 ng/mL.

Results: VitD3-supplementation significantly increased mean 25(OH)D by 2.7-fold and 24,25-dihydroxyvitamin D [24,25(OH)2D] by 4.3-fold. In contrast, mean levels of PTH, FGF23, and 1,25(OH)2D did not change. Mathematical modeling suggested that 24-hydroxylase activity was maximal for 25(OH)D≥50 ng/mL and achieved a minimum (~90% suppression) with 25(OH)D<10-20 ng/mL. The 1,25(OH)2D/24,25(OH)2D ratio better predicted modeled 24-hydroxylase activity (h) (ρ=-0.85; p=0.001) compared to total plasma 25(OH)D (ρ=0.51; p=0.01) and the 24,25(OH)2D/25(OH)D ratio (ρ=0.37; p=0.3).

Conclusions: Suppression of 24-hydroxylase provides a first line of defense against symptomatic VitD-deficiency by decreasing metabolic clearance of 1,25(OH)2D. The 1,25(OH)2D/24,25(OH)2D ratio provides a useful index of VitD status since it incorporates 24,25(OH)2D levels and therefore, provides insight into 24-hydroxylase activity. When VitD availability is limited, this suppresses 24-hydroxylase activity - thereby decreasing the level of 24,25(OH)2D and increasing the 1,25(OH)2D/24,25(OH)2D ratio. Thus, an increased 1,25(OH)2D/24,25(OH)2D ratio signifies triggering of homeostatic regulation, which occurs at early stages of VitD-deficiency.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
After the Infection: A Survey of Pathogens and Non-communicable Human Disease. The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 Diabetes. Keyphrase Identification Using Minimal Labeled Data with Hierarchical Contexts and Transfer Learning. Advancing Efficacy Prediction for EHR-based Emulated Trials in Repurposing Heart Failure Therapies. Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1